BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6119322)

  • 21. [LATS and other antibodies against the TSH receptor].
    Rodríguez Zapata MM
    Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881
    [No Abstract]   [Full Text] [Related]  

  • 22. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?
    Brown RS; Jackson IM; Pohl SL; Reichlin S
    Lancet; 1978 Apr; 1(8070):904-6. PubMed ID: 76846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid-stimulating immunoglobulins.
    Pinchera A; Fenzi GF; Macchia E; Bartalena L; Mariotti S; Monzani F
    Horm Res; 1982; 16(5):317-28. PubMed ID: 6129186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologic aspects of Graves' and Hashimoto's diseases.
    Kidd A; Okita N; Row VV; Volpé R
    Metabolism; 1980 Jan; 29(1):80-99. PubMed ID: 6986013
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.
    Zakarija M; McKenzie JM; Munro DS
    J Clin Invest; 1983 Oct; 72(4):1352-6. PubMed ID: 6138363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can LATS be detected by immunofluorescence?
    Beall GN; Solomon DH; Doniach D; Roitt IM
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1114-6. PubMed ID: 4895860
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient Graves' hyperthyroidism during pregnancy in a patient with Hashimoto's hypothyroidism.
    Lu R; Burman KD; Jonklaas J
    Thyroid; 2005 Jul; 15(7):725-9. PubMed ID: 16053390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of subgroups of euthyroid graves's ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith FJ
    N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
    Holmes SD; Dirmikis SM; Martin TJ; Munro DS
    J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.
    Munro DS; Dirmikis SM; Humphries H; Smith T; Broadhead GD
    Br J Obstet Gynaecol; 1978 Nov; 85(11):837-43. PubMed ID: 581471
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism.
    Zakarija M; McKenzie JM; Hoffman WH
    J Clin Endocrinol Metab; 1986 Feb; 62(2):368-71. PubMed ID: 2867106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
    Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
    [No Abstract]   [Full Text] [Related]  

  • 36. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
    McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
    Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
    Kendall-Taylor P
    Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
    Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
    J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.
    Yagi H; Takeuchi M; Nagashima K; Suzuki S; Kuroume T; Iida Y; Konishi J; Endo K
    J Pediatr; 1983 Oct; 103(4):591-3. PubMed ID: 6137525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.